Biolife Solutions (BLFS) Total Current Liabilities (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Total Current Liabilities data on file, last reported at $18.3 million in Q1 2026.

• On a quarterly basis, Total Current Liabilities fell 34.16% year-over-year to $18.3 million in Q1 2026; TTM through Mar 2026 was $18.3 million, a 34.16% decrease from a year earlier, with the FY2025 full-year figure at $23.0 million, down 29.8% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $18.3 million, down from $23.0 million in the prior quarter.
• Over the last five years, Total Current Liabilities for BLFS reached as high as $47.3 million in Q1 2023 and fell as low as $18.3 million in Q1 2026.
• Historically, Total Current Liabilities has averaged $34.7 million across 5 years, with a median of $36.4 million in 2022.
• Across the five-year window, Total Current Liabilities surged 130.46% in 2022 and slumped 34.16% in 2026, its largest moves.
• Year by year, Total Current Liabilities stood at $44.6 million in 2022, then dropped by 5.39% to $42.2 million in 2023, then fell by 22.39% to $32.7 million in 2024, then dropped by 29.8% to $23.0 million in 2025, then declined by 20.57% to $18.3 million in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $18.3 million in Q1 2026, $23.0 million in Q4 2025, and $27.1 million in Q3 2025.